HIF-3αノックアウトとHIF-2αノックダウンを組み合わせたマウスに基づく肺胞発生解析 by ZULKIFLI AMIN FIRMAN
Analysis of the alveolar development based on
the mice with the combined HIF-3α knockout
and HIF-2α knockdown
著者（英） ZULKIFLI AMIN FIRMAN
year 2019
その他のタイトル HIF-3αノックアウトとHIF-2αノックダウンを組み
合わせたマウスに基づく肺胞発生解析
学位授与大学 筑波大学 (University of Tsukuba)
学位授与年度 2018
報告番号 12102甲第8882号
URL http://doi.org/10.15068/00156452
	 
 
筑 波 大 学 
 
博 士 (医 学) 学 位 論 文 
 
 
		
 
 
 
 
 
Analysis of the alveolar development based on  
the mice with the combined HIF-3α knockout 
and HIF-2α knockdown 
 （HIF-3αノックアウトと HIF-2αノックダウンを組
み合わせたマウスに基づく肺胞発生解析）	
 
 
 
 
 
2018 
 
筑波大学大学院博士課程人間総合科学研究科 
 
FIRMAN ZULKIFLI AMIN 
		
Table of contents 
Chapter I. General overview       1 
1.1. Purpose          1 
1.2. Material and method        1 
1.3. Result          2 
1.4. Conclusion         2 
1.5. Abbreviation         3 
Chapter II. Deterioration of alveolar development in mice with both  
HIF-3α -/- and HIF-2α kd/kd       5 
2.1. Introduction         5 
2.1.1. The importance of studies on lung development    5 
2.1.2. The process occurring early in lung development    5 
2.1.3. Alveologenesis as a crucial phase in lung development  
for gas exchange readiness       7 
2.1.4. The role of the hypoxic environment in lung development  8 
2.1.5. The regulating of hypoxia-inducible factors in lung development 10 
2.2. Materials and methods        12 
2.2.1. The generation of the double-mutant mice from HIF-3α -/- and  
HIF-2α kd/+ mice        12 
2.2.2. Genotyping for HIF-2α and HIF-3α gene of the double-mutant mice  
from HIF-3α -/- and HIF-2α kd/+ mice      13 
2.2.3. Isolation and culture of cells      14 
2.2.4. Immunohistochemistry and section staining    15 
2.2.5. Quantitative reverse transcription polymerase chain reaction (qPCR) 16 
2.2.6. Statistical analysis        17 
	2.3. Results          17 
2.3.1. No double-mutant mice died immediately after birth   17 
2.3.2. The double-mutant mice had not died embryonically   18 
2.3.3. The neonatal double-mutant mice showed the impaired alveolar sacs  
and lung alveolar structure       19 
2.3.4. The neonatal double-mutant mice showed the impaired expression of  
HIF-1α, HIF-2α, VE-cadherin, and VCAM-1 in lung tissues   21 
2.3.5. The neonatal double-mutant mouse lung cells exhibited suppressed  
expressions of HIF-1α and HIF-2α      23 
2.3.6. The neonatal double-mutant mouse lung cells exhibited  
the downregulation of HIF-target genes denoted by VE-cadherin,  
VCAM-1, Ang-2, Tie-2, and VEGF      24 
2.3.7. The neonatal double-mutant mice showed the decreased  
endothelial cell numbers        26 
2.4. Discussion         28 
Chapter III. Conclusion and perspectives      37 
3.1. Conclusion         37 
3.2. Perspectives         37 
References          39 
Acknowledgments         47 
Citation          49 
 
 
 
	1		
Chapter I. General overview  
 
1.1. Purpose 
Studying the lung development to clarify the underlying mechanisms of 
diseases or the molecular identity of various cell types may provide further strategies 
to comply in models of human lung disease. In relation to this, previous studies using 
adult mice with single-mutation consisted of hypoxia-inducible factor 3α (HIF-3α) 
knockout (-/-) showed the impairments in lung remodeling and lung endothelial cells. 
Another previous research demonstrated that impaired expression of hypoxia-
inducible factor 2α (HIF-2α) induced compensatory expression of hypoxia-inducible 
factor 1α (HIF-1α) in HIF-2α knockdown (HIF-2α kd/kd) mice. This recent study 
hence learns from those previous studies to uncover more insights by extending the 
investigation, utilizing neonatal mice with double-mutation consisted of both HIF-3α -
/- and HIF-2α kd/kd aiming to recover the impaired lung conditions due to the single-
mutation.  
 
1.2. Materials and methods 
Firstly, the wild-type (WT) and mutant mouse lines were maintained on the 
C57BL/6J genetic background. The HIF-2α kd/kd mice and HIF-3α -/- (single-
mutant) mice were each generated. Concerning this, the mating of single-mutant and 
HIF-2α knockdown heterozygotes (HIF-2α kd/+) mice resulted in the combined HIF-
3α -/- and HIF-2α kd/kd mice, which were called the double-mutant mice. 
Furthermore, the lungs from each of the WT and double-mutant mice were dissected 
at postnatal day 0 (P0) for hematoxylin and eosin staining and immunological staining 
with CD31, HIFs, VE-cadherin, and VCAM-1 antibodies. The lungs from each of the 
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WT, HIF-2α kd/kd, single-mutant, and double-mutant mice were dissected at 
postnatal 6-week-old for cell culture. Also, the gene expression of HIFs and their 
target genes were analyzed by quantitative reverse transcription polymerase chain 
reaction (qPCR). 
 
1.3. Results 
No mice with both HIF-3α -/- and HIF-2α kd/kd died immediately after birth. 
The double-mutant mice with both HIF-3α -/- and HIF-2α kd/kd exhibited impaired 
lung alveolar structure and HIFs expression. Transcriptional analysis of lung cells 
revealed the depressed expressions of HIF-1α, HIF-2α, VE-cadherin, VCAM-1, Tie-2, 
and Ang-2 in the double-mutant mice compared to that in the WT mice. The 
endothelial cell numbers were also decreased in the double-mutant mice as opposed to 
the WT mice. 
 
1.4. Conclusion 
The current study proposed the insightful ideas of the role of both HIF-3α and 
HIF-2α in lung development, which involved in the low number of endothelial cells 
and the impaired expression of angiogenic factors. Further studies are necessary to 
elucidate the underlying mechanism of how HIF-3α and HIF-2α regulate the lung 
endothelial cells as well as lung development. Nevertheless, it is apprehensible that 
studies of HIF-dependent responses on pulmonary vascular and airway epithelium are 
equally important. Thus, the future perspective on the present study will need to aim 
at elucidating the functional role of double-mutation consisted of both HIF-3α -/- and 
HIF-2α kd/kd in lung endothelial cells and alveolar epithelial cells of the double-
mutant mice. 
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1.5. Abbreviation 
AT1: Alveolar type 1 
AT2: Alveolar type 2 
Ang-1: Angiopoietin 1 
Ang-2: Angiopoietin 2 
ARNT: Aryl hydrocarbon receptor nuclear translocator 
bHLH: Basic helix-loop-helix 
CAD: C-terminus transactivation domain 
CBP: CREB-binding protein 
cDNA: Complementary deoxyribonucleic acid 
CO2: Carbon dioxide 
DMEM: Dulbecco’s modified Eagle’s medium 
FBS: Fetal bovine serum 
FIH: Factor inhibiting hypoxia-inducible factor 
HAVA: High glucose Dulbecco’s modified Eagle’s medium supplemented with 10% 
fetal bovine serum, 0.1 mmol/L nonessential amino acids, 2 mmol/L L-glutamine, 
penicillin-streptomycin, and 10-4 mol/L β-mercaptoethanol 
HIF: Hypoxia-inducible factors 
HIF-1α: Hypoxia-inducible factor 1α 
HIF-2α: Hypoxia-inducible factor 2α 
HIF-3α: Hypoxia-inducible factor 3α 
HRE: Hypoxia-responsive element 
kd/kd: Knockdown 
kd/+: Knockdown heterozygotes 
mRNA: Messenger ribonucleic acid  
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n: Sample number 
OCT: Optimum cutting temperature 
ODD: Oxygen-dependent degradation 
P: Postnatal day 
PAS: PER-ARNT-SIM 
PCR: Polymerase chain reaction 
PHD: Proline hydroxylase  
pVHL: Von Hippel-Lindau tumor suppressor 
qPCR: Quantitative real-time polymerase chain reaction 
RNA: Ribonucleic acid 
VCAM-1: Vascular cell adhesion molecule 1 
VE-cadherin: Vascular endothelial cadherin 
VEGF: Vascular endothelial growth factor 
WT: Wild-type 
-/-: Knockout 
+/+: Homozygotes 
+/-: Knockout heterozygotes 
µm: Micrometer 
°C: Celsius degree 
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Chapter II. Deterioration of alveolar development in mice with both HIF-3α -/- 
and HIF-2α kd/kd 
 
2.1. Introduction 
2.1.1. The importance of studies on lung development 
Recent progress in regenerative medicine studies toward lung development has 
served many new advances about the background mechanisms involved. 
Nonetheless, there has still remained a gap of knowledge regarding the 
respiratory system ability in response to injury and disease.  
The study of lung development is essential accordingly due to the fact that it 
can provide the underlying mechanisms to be taken care of for instance in the 
event of perinatal infection along with inflammation interfering with 
alveologenesis leading to bronchopulmonary dysplasia [1]. Another example of 
its importance can be in the form of knowing more detailed about molecular 
identity of various cell types that may provide further strategies to comply with 
the behavior of stem or progenitor cells in models of human lung disease. 
Therein, it is of necessity to depict of the mechanisms developing the respiratory 
system. 
 
2.1.2. The process occurring early in lung development 
Principally, the respiratory system of mammalian as in both of the adult 
human and mouse lung is similar. The lungs along with the trachea emerge from 
the anterior foregut endoderm. The latter is a tissue resulting in multiple organs, 
which involve the respiratory system, esophagus, thyroid, and liver. The 
specification of lung starts around embryonic day (E) 9.0 in the mouse marked by 
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the transcription factor Nkx2-1 that is expressed in endodermal cells on the 
ventral side of the anterior foregut. At E9.5, evagination of those epithelial cells 
produces in the formation of the trachea and two lung buds and the onset of the 
embryonic stage of lung development (E9.5 - E12.5). Through this phase, the 
trachea accomplishes its splitting from the esophagus. Furthermore, throughout 
the embryonic and pseudoglandular phases (E12.5 - E16.5), the two lung buds 
serve a highly arranged branching process named branching morphogenesis to 
yield a tree-like composition of airways accompanied by thousands of terminal 
branches [2–6].  
Of the branching morphogenesis, two primary lung buds appearing around 
E9.5 in the mouse and 4-5 weeks gestation in the human provide the increment to 
the airway tree. The buds are arranged of a simple endodermal epithelium that the 
surrounding is mesoderm and a vascular plexus. The tissues are enwrapped in a 
thin layer of mesothelium leading a transient early role to mesenchymal lineages 
[7]. The buds elongate and diverge in a scheme that is at first really stereotypic 
but reduces further as development proceeds [4, 8, 9].  
All lung endodermal cells in the beginning express Nkx2-1, by which this 
marker continues firmly into the adult. Nonetheless, along with the primary buds 
elongate and diverge, a distinct scheme of gene expression arises in the endoderm 
of the stalks compared to the buds. This proximal-distal difference is indicated by 
the expression domains of Sox2 and Sox9, which are two transcription factors 
needed for early lung development. Sox2 expression is limited to the proximal 
stalks. On the other hand, Sox9 is vibrantly expressed in the much higher 
proliferative cuboidal cells of the distal buds [10, 11]. 
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2.1.3. Alveologenesis as a crucial phase in lung development for gas exchange 
readiness 
In the mouse prenatal alveologenesis, at about E15, branching morphogenesis 
decreases and notable changes occur in the distal epithelium. The canalicular 
(E16.5 - E17.5) and saccular (E18.5 - postnatal day (P) 5) phases have followed 
on, by which those terminals branches narrow and make clusters of epithelial cell 
that will further develop into alveoli in the arrangement for respiration at birth. 
The tubes that have become canalicular have more tightly related to the 
surrounding vasculature. Cells located in the distal side of the tubules start to 
express genes trait of alveolar epithelial type 1 (AT1) and 2 (AT2) cells, which 
arrange for the mature alveoli. AT1 cells express Hopx, podoplanin (Pdpn, 
notable as T1alpha), and AGER. On the other side, AT2 cells express proteins 
correlated with high levels of surfactant production and secretion e.g. SftpA-C 
[12]. Furthermore, the tubules that get into the saccular stage implicate the 
budding of very small peripheral sacs outcast by primary septa. Postnatally, these 
sacs are then divided again by secondary septa.  
In the mouse postnatal alveologenesis, the establishment of the alveoli does 
not finish at birth. The alveoli number and surface area rises significantly 
postnatally and keeps on for weeks in the mice and months in the humans with 
the development of new secondary septa. Ultimately, full maturation of the 
alveolus happens in the course of the alveolarization phase (P0 - P14). Through 
all phases of endodermal development, the lung mesoderm (or mesenchyme) 
expands and cooperates with the lung endoderm to promote branching and 
differentiation and to yield the various lineages within the lung, which involves 
airway and vascular smooth muscle and pericytes [2–6].  
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2.1.4. The role of the hypoxic environment in lung development 
The respiratory process in lung takes place in the alveoli that consist of 
alveoli, alveolar duct, and alveolar sacs. Alveolar sacs are composed of AT1 and 
AT2 cell. Gas exchange occurring in the alveoli is mediated by AT1, by which 
oxygen from alveoli will enter the blood circulation through endothelial cells to 
go throughout the body and vice versa for the carbon dioxide. On the other side, 
AT2 cells will maintain alveolar fluid balance or fluid homeostasis; produce 
surfactant proteins [13, 14]; and are adult stem cells, competent of both self-
renewal and differentiation into AT1 cells [15–18].  
In utero, the fetal lung develops in a relatively hypoxic environment. Most 
hypoxia-induced regulatory states are mediated by HIFs giving the contribution 
to normal lung development [19]. HIFs are heterodimers that consist of three 
oxygen-sensitive α-subunits (HIF-1α, HIF-2α, and HIF-3α) and a β-subunit, the 
aryl hydrocarbon receptor nuclear translocator (ARNT) [20, 21]. Under the 
normoxic condition, the proline residue on oxygen-dependent degradation (ODD) 
domain of HIF is hydroxylated by proline hydroxylase (PHD) using oxygen in 
the cytosol (Figure 1) [22, 23].  E3 ubiquitin ligase recognizes hydroxyl proline 
and ubiquitinates HIF protein. Ubiquitinated HIF protein is degraded 
immediately. On the other side, under the hypoxic condition, PHD cannot 
undergo hydroxylation because there is no substrate for hydroxylation. HIF 
protein is stabilized and dimerized with ARNT, then, bind to the hypoxia-
responsive element (HRE) enhancer leading to activation of HIF-target genes [24, 
25].  
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Figure 1. The regulation of HIFs during normoxic and hypoxic conditions. 
ARNT, aryl hydrocarbon receptor nuclear translocator; CBP, CREB-binding 
protein; FIH, factor inhibiting hypoxia-inducible factor; HIF, hypoxia-inducible 
factor; PHD, proline hydroxylase; pVHL, von Hippel-Lindau tumor suppressor. 
 
Both HIF-1α and HIF-2α have strong transcriptional activities for binding to 
HRE. While, HIF-3α transcription activity is weaker compared to HIF-1α and 
HIF-2α because of no C-terminus transactivation domain (CAD) in the structure 
(Figure 2) [20, 26].  
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Figure 2. The role of CAD in the structure of HIFs. ARNT, aryl hydrocarbon 
receptor nuclear translocator; bHLH, basic helix-loop-helix; CAD, C-terminus 
transactivation domain; HIF, hypoxia-inducible factor; HRE, hypoxia-responsive 
element; ODD, oxygen-dependent degradation; PAS, PER-ARNT-SIM. 
 
2.1.5. The regulating of hypoxia-inducible factors in lung development 
The lung development is widely known to occur in a hypoxic environment. 
Therefore, HIFs have without any wonder become the substantive contributors to 
embryogenesis. The mRNA and protein levels of HIFs have sufficiently high in 
the fetal lung [27–29]. In human, the whole system of HIFs has started from 8 
weeks of gestation [28]. Hypoxia generated the protein expression of HIF-1α in 
cultured cells that came from, showing control, all kind of cells known in the 
adult lung [30]. Meanwhile, the protein expression of HIF-2α limited only control 
to the vascular endothelium and AT2 cells [31].  
The lung of the normal embryo is at the hypoxic stage throughout fetal 
development [32]. HIF-1α protein is at high levels, which primarily restricted in 
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branching epithelium based on analysis of the spatial pattern of expression in the 
lungs of human through the early development of the pulmonary vasculature. 
HIF-2α has as well presented in the epithelium, and also in mesenchymal 
structures that provide the increase to the vascular endothelium [28]. 
Many of HIF-target genes involved in endothelial cell proliferation and 
survival, for instance, angiopoietin 1 (Ang-1) and 2 (Ang-2) [24]. Nevertheless, 
all members of the HIF regulating pathway, in the human fetal lung, is also 
expressed in the epithelium [28, 33]. HIFs act as regulators of the molecular 
hypoxic response [20, 21]; in a study examining normal alveolarization in 
fostered newborn rats, HIFs promoted alveolar development and regeneration by 
preventing and repairing oxygen-induced alveolar damage [34]. Nonetheless, 
HIF-1α inhibition using antisense knockdown in vitro during early lung 
development decreased vascular development and epithelial branching 
morphogenesis in lung explants [35]. In contrast, the conditional overexpression 
of HIF-1α in embryonic lung epithelium also impaired branching morphogenesis 
and lung maturation and affected vascular lung abnormalities, including 
hemorrhages and increased lymphangiogenesis [36]. Collectively, these data 
suggest that interference in the alveolar epithelium by oxygen pressure changes, 
including hypoxia, can affect alveolar homeostasis, leading to epithelial injuries 
and diseases such as lung fibrosis [37–40].  
A previous study that used adult single-mutant mice with HIF-3α -/- showed 
impaired lung remodeling exhibited by the walls of the secondary septa in 
subdivided alveoli, and immunostaining of alveolar endothelial cells presented an 
increase in defective space in the interalveolar septa and hyperplasia of 
endothelial cells during the maturation of alveolar formation in these knockout 
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mice [26]. Additionally, another study on the lung endothelial cells of adult 
single-mutant mice revealed that the defect of HIF-3α induced HIF-2α 
overexpression, and excess HIF-2α caused overproduction of VE-cadherin. 
Hence, the adult single-mutant mice showed impairments in lung endothelial cells 
presented by slow growth and a decreased number of tubes formed by endothelial 
cells [41]. Furthermore, a different but related study preceding the present study 
demonstrated that impaired expression of HIF-2α in HIF-2α kd/kd mice induced 
compensatory expression of HIF-1α [42]. The current study uncovers more 
insights by extending the investigation from those previously stated findings 
before the current study utilizing the double-mutant mice with both HIF-3α -/- 
and HIF-2α kd/kd. The purpose of the current study using mice with the double-
mutation of both HIF-3α -/- and HIF-2α kd/kd is to recover the impaired lung 
conditions due to the single-mutation of HIF-3α -/-. For this reason, in this study, 
male and female HIF-3α -/- and HIF-2α kd/+ mice were interbred, resulting in the 
double-mutant mice previously mentioned. 
 
2.2. Materials and methods 
2.2.1. The generation of the double-mutant mice from HIF-3α -/- and HIF-2α 
kd/+ mice 
All of the experiments performed were approved by the ethics committee of 
the University of Tsukuba. All WT and mutant mouse strain were of the 
C57BL/6J genetic background. Because the HIF-2α -/- causes the embryonic 
mortality, the HIF-2α kd/kd mice were selected for the present study. In order to 
obtain the HIF-2α kd/kd mice, firstly, the HIF-2α kd/+ mice, which are 
heterozygous, were generated as previously reported for the mutated HIF-2α gene 
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[43]. Briefly, a targeting vector was inserted a PGK promoter-neomycin gene 
cassette, which was a sandwiched between two loxP sequences into upstream 
exon 1 that encoded the 5’-UTR sequence by homologous recombination. This 
vector was utilized to disrupt the mouse HIF-2α gene. Next, the heterozygous 
embryonic stem (ES) cell line for the recombinant allele as for HIF-2α kd/+ was 
utilized to generate the chimeric mice by blastocyst injection. The resulting 
chimeric mice were crossed with WT mice to obtain the HIF-2α kd/+ mice. The 
resulting HIF-2α kd/+ mice were thereafter interbred with each other to yield the 
HIF-2α kd/kd mice. The generating mice were genotyped for HIF-2α gene. 
HIF-3α -/- mice were obtained as previously published [41]. Briefly, a 
pBluescript SK(+) vector contained the chimeric DNA replacing part of the 
second exon. The following intron of the HIF-3α gene and a neomycin resistance 
gene were sandwiched between loxP sequences. Thereafter, the GFP gene was 
constructed. Then, the vector was transfected into ES cells resulting in 
recombinant ES cells that were hence injected into WT mice by blastocyst 
injection. The resulting chimeric mice were intercrossed with WT mice obtaining 
HIF-3α -/- mice that the generating mice were genotyped for HIF-3α gene. 
In order to generate the double-mutant mice, the mating of 12 pairs of HIF-3α 
-/- and HIF-2α kd/+ mice for a breeding period of one year was performed. The 
double-mutant neonatal pups were confirmed by genotyping for HIF-2α and HIF-
3α. 
 
2.2.2. Genotyping for HIF-2α and HIF-3α gene of the double-mutant mice 
from HIF-3α -/- and HIF-2α kd/+ mice 
The genome DNA was extracted from the tail of the neonatal pups. The 
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genotype of the mouse was determined by polymerase chain reaction (PCR). The 
sequences of primer for HIF-3α genotyping were 5’-primer 
TGCCATTTCCTTCCCACAGGTCGAACACCG and 3’-primer 
CTTGGATTTGGGTTCAATCTCCAGTATGGC, and for HIF-2α genotyping 
were 5’-primer TCGGCAGTGTCCTGAGACTG and 3’-primer 
AAGGGACCTGGAGTTCCGTT.  
 
2.2.3. Isolation and culture of cells 
In order to analyze the expression of HIFs and their target genes, and clarify 
the molecular mechanisms by which HIFs affect the lung development, the whole 
lung cells were isolated and cultured. The overdose treatment of anesthetic 
reagent (isoflurane; WAKO, Japan) was given to the WT, HIF-2α kd/kd, HIF-3α 
-/-, and double-mutant mice that were sacrificed, and lung tissues from these mice 
were harvested as previously mentioned [44]. Furthermore, lungs from the WT, 
HIF-2α kd/kd, HIF-3α -/-, and double-mutant mice were dissected at postnatal 
week 6 for cell culture. Collagenase digestion (Nitta Gelatin, Osaka, Japan) was 
used to prepare the lung cell suspensions. Afterward, these cells were cultured, in 
high glucose Dulbecco’s modified Eagle’s medium (DMEM; GIBCO) 
supplemented with 10% fetal bovine serum (FBS), 0.1 mmol/L nonessential 
amino acids, 2 mmol/L L-glutamine, penicillin-streptomycin, and 10-4 mol/L β-
mercaptoethanol (HAVA medium) [40], and maintained at 33°C in 20% CO2 
without any addition of growth supplements for a total of 7 days with no 
propagation. 
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2.2.4. Immunohistochemistry and section staining   
The lungs dissected at P0 that obtained from three mice (n = 3) from each of the 
WT, single-mutant, and double-mutant mice for hematoxylin and eosin staining 
and at P2-P3 from each of the WT and double-mutant mice for immunological 
staining, which were fixed with 4% paraformaldehyde combined with phosphate-
buffered saline at 4°C overnight and embedded in OCT compound (Sakura 
Finetek, Tokyo, Japan). Sections (10 µm) were then prepared for hematoxylin 
and eosin staining and immunological staining. Sections were washed with 
phosphate-buffered saline (PBS) for removing OCT compound and soaked into 
Mayer’s hematoxylin solution (Wako, Osaka, Japan) at 3 minutes. After washing 
with water, sections were soaked into eosin solution (Wako) at 30 seconds. 
Samples were dehydrated with ethanol series and penetrated with xylene. Section 
was mounted with Malinol (Muto pure chemical, Tokyo, Japan). Serial cryostat 
sections were incubated with anti CD31 (1:1000; clone: MEC 13.3; BD 
Biosciences, San Diego, CA, USA) antibody. The sections, after being washed, 
were incubated with an HRP-conjugated secondary antibody (1:2000; Vector 
Laboratories, Burlingame, CA, USA). Different sections were incubated with 
anti-HIF-1α, anti-HIF-2α (1:1000; Novus Biologicals, CO, USA), anti-vascular 
cell adhesion molecule 1 (VCAM-1), and anti-vascular endothelial cadherin (VE-
cadherin) (1:200; Santa Cruz Biotechnology Inc. Texas, USA) antibodies for 
overnight at 4°C. After washing 3 times, sections were incubated with the biotin-
conjugated secondary antibody (1:2000; Vector Laboratories). After washing, 
sections were treated with ABC labeling kit (Vector Laboratories), and the 
positive signal was stained with 3,3’-diaminobenzidine reagent (Dojindo, Japan). 
The sample sections were counterstained with hematoxylin (Wako). The CD31-
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positive cell number was counted by the observation using the microscope 
(Olympus, Tokyo, Japan). The number of the CD31 positive cell was shown as 
the value per field (200x higher magnification). For a sample, a total of nine 
fields from three slides of the sample was randomly selected out of one section 
and counted. The experiment was performed in triplicate. 
 
2.2.5. Quantitative reverse transcription polymerase chain reaction (qPCR)  
Total RNA was obtained from three samples of three independent mice (n = 3) 
with the use of the extraction reagent (Sepasol-RNA I Super G; Nakalai Tesque, 
Kyoto, Japan). The cDNA was then synthesized by reverse transcription from one 
microgram of total RNA using a reverse transcriptase (RT)-polymerase chain 
reaction (PCR) kit  (ReveTra Ace; TOYOBO, Osaka, Japan). The resulting 
cDNAs were analyzed using a GeneAmp PCR System (Life Technologies, CA) 
with 25-35 cycles of denaturation at 95oC for 5 seconds followed by annealing 
and extension at 68°C for 30 seconds then performed a fluorescence reading step. 
The reaction mixtures for the quantitative PCR were prepared by using SYBR-
Green Real-Time PCR Mastermix (Life Technologies, Carlsbad, CA, USA) and 
analyzed by using a 7500 Fast Real-Time PCR machine (Applied Biosystems, 
Carlsbad, CA, USA) with SYBR-green. Experiments were performed in 
triplicate, and the resulting data were analyzed by the delta CT method. The 
sequences of primer used for this method were as follows: β-actin was 5’-primer 
GTCGTACCACAGGCATTGTGATGGACT and 3’-primer 
CACCAGAGAGCACTGTGTTGGCATAGA; HIF-1α was 5’-primer 
GAAGCACCTTCCACGTTGCTGACTTGAT and 3’-primer 
CAAGATCTCGGCGAACGAAAGAGTCTGA; HIF-2α was 5’-primer 
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CTTTGTGTGTGTTGAGAGTTTTATTGT and 3’-primer 
AAGGAAGTTAGGATTCACAAATGTAGT; VE-cadherin was 5’-primer 
CCGCCAGAATGCTAAGTATGTGC and 3’-primer TCCACAATGAGGGC 
AGTAAGGAA; and VCAM-1 was 5’-primer 
GAACACTTTTCCCAGACACTTTTCACGTGG and 3’-primer 
TAAGGATCTGGGTTTTATAAATAATGTCTC. 
 
2.2.6. Statistical analysis  
The ANOVA.SPSS software (IBM Corp., NY, USA) was used to perform the 
statistical analyses. The p values of <0.05 are considered significance. The data 
are presented as the mean ± standard deviation (SD). 
 
2.3. Results 
2.3.1. No double-mutant mice died immediately after birth 
In order to study the role of both HIF-2α and HIF-3α in lung development, I 
performed the mating of single-mutant and HIF-2α kd/+ mice. Interbreeding 
between male and female single-mutant and HIF-2α kd/+ mice resulted in 198 
offspring within one week (Figure 3). Of the total number of offspring, 5.1% 
were surprisingly the double-mutant mice, with very few pups still alive at birth, 
34.3% were HIF-3α -/- and HIF-2α +/+, and 60.6% were HIF-3α -/- and HIF-2α 
kd/+. Almost none of the double-mutant mice were alive at birth. The majority of 
double mutant mice died within one week after birth due to respiratory failure 
resulting in the survived mice.  
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Figure 3. No double-mutant mice died immediately after birth. The offspring 
from the interbreeding of male and female single-mutant and HIF-2α kd/+ mice 
comprised HIF-3α -/- and HIF-2α +/+ mice, HIF-3α -/- and HIF-2α kd/+ mice, 
and double-mutant mice. H3, hypoxia-inducible factor 3α; H2, hypoxia-inducible 
factor 2α; ::, intercrossed with; -/-, knockout; kd/+, knockdown heterozygotes; 
+/+, homozygotes; ♂, male; ♀, female. 
 
2.3.2. The double-mutant mice had not died embryonically  
In E12.5, I checked the embryo development of double-mutant mice. The 
double-mutant mice had not died embryonically, and vasculogenesis on yolk sac 
and hematopoiesis (fetal liver) were nothing different in between the genotypes of 
HIF-3α -/- and HIF-2α +/+, HIF-3α -/- and HIF-2α kd/+, and double-mutant mice 
(Figure 4). These data clarified that the double-mutant mice were died later, even 
though have been shown not immediately, after birth. 
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Figure 4. The double-mutant mice had not died embryonically. At E12.5, the 
littermate mice were analyzed by using Stereomicroscope. The vascular on yolk 
sac and fetal liver of double-mutant mice were nothing different compared to 
other genotype mice. H3, hypoxia-inducible factor 3α; H2, hypoxia-inducible 
factor 2α; ::, intercrossed with; -/-, knockout; kd/+, knockdown heterozygotes; 
KO, knockout; +/+, homozygotes. 
 
2.3.3. The neonatal double-mutant mice showed the impaired alveolar sacs 
and lung alveolar structure 
The previous report from my laboratory described that adult single-mutant 
mice with HIF-3α -/- showed an enlargement of the right ventricular and impaired 
lung remodeling during development [26]. Therefore, in the present study, firstly 
I examined the influences of double-mutation on the lung of the mice. 
Hematoxylin and eosin staining of the lung in the neonatal WT, single-mutant, 
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and double-mutant mice was performed at P0 (Figure 5). In contrary to the 
expectation from the study purpose, I found that double-mutation caused the 
impaired structure of the lungs. In particular, alveolar sacs were found almost 
imperceptible in the lungs of neonatal double-mutant mice, and the appearance of 
the blood vessels in the lungs of these mice was different from that in the lungs of 
neonatal single-mutant and WT mice. The neonatal double-mutant mice had less 
immature alveoli with a lot of broader alveolar sacs as compared with the 
neonatal single-mutant mice. There is no phenotype data for neonatal HIF-2α 
kd/kd mice at present. All of these showed important roles of both HIF-3α and 
HIF-2α in lung development and may further suggest the possibility of the 
relationship among HIFs. 
 
Figure 5. The neonatal double-mutant mice had the impaired alveolar sacs and 
lung alveolar structure. The lung of neonatal WT mice, neonatal single-mutant 
mice, and neonatal double-mutant mice at P0 was examined based on 
hematoxylin and eosin staining. H3, hypoxia-inducible factor 3α; H2, hypoxia-
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inducible factor 2α; ::, intercrossed with; -/-, knockout; kd/kd, knockdown; WT, 
wild-type. 
 
2.3.4. The neonatal double-mutant mice showed the impaired expression of 
HIF-1α, HIF-2α, VE-cadherin, and VCAM-1 in lung tissues 
In order to study the relationship among HIFs in lung development, I 
thereafter examined the expression of HIF-1α and HIF-2α in lung tissues of the 
neonatal double-mutant mice by immunological staining. I found that the 
neonatal double-mutant mice showed the impaired expressions of both HIF-1α 
and HIF-2α in lung tissues (Figure 6).  
 
Figure 6. The double-mutant mice showed the impaired expression of HIF-1α 
and HIF-2α in lung tissues. Immunohistochemistry analysis performed to sections 
from the neonatal WT and double-mutant mice at two to three days of age by 
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staining with HIF-1α and HIF-2α antibodies. H3, hypoxia-inducible factor 3α; 
H2, hypoxia-inducible factor 2α; ::, intercrossed with; -/-, knockout; kd/kd, 
knockdown; WT, wild-type; HIF-2α, hypoxia-inducible factor 2α; HIF-1α, 
hypoxia-inducible factor 1α; µm, micrometer.  
 
 Next, I examined the expression of HIF-target genes in lung tissues. I found 
that consistent with the impaired expression of HIF-1α and HIF-2α, the neonatal 
double mutant mice lung also showed the impaired expression of adhesion 
molecules denoted by VE-cadherin and VCAM-1 (Figure 7). 
 
Figure 7. The double-mutant mice showed the impaired expression of VE-
cadherin and VCAM-1 in lung tissues. Immunohistochemistry analysis performed 
to sections from the neonatal WT and double-mutant mice at two to three days of 
age by staining with VE-cadherin and VCAM-1 antibodies. H3, hypoxia-
inducible factor 3α; H2, hypoxia-inducible factor 2α; ::, intercrossed with; -/-, 
knockout; kd/kd, knockdown; WT, wild-type; VE-cadherin, vascular endothelial 
cadherin; VCAM-1, vascular cell adhesion molecule 1; µm, micrometer. 
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2.3.5. The neonatal double-mutant mouse lung cells exhibited suppressed 
expressions of HIF-1α and HIF-2α 
Kobayashi et al. reported the increased mRNA expression of HIF-2α, but not 
HIF-1α, by HIF-3α ablation in the pulmonary endothelial cells isolated from the 
adult single-mutant mice having such HIF-3α -/- compared to those from the 
adult WT mice, suggesting the role of HIF-3α in the regulation of HIF-2α [41]. 
Therefore, next, I examined the transcriptional relation of HIFs in the whole lung 
cells isolated from the neonatal WT, HIF-2α kd/kd, single-mutant, and double 
mutant mice. This analysis utilized the whole lung cells isolated at two to three 
days of age, and the relative mRNA expression levels were examined. 
Inconsistent with the finding utilizing the adult single-mutant mice showing no 
effects of HIF-3α on the expression of HIF-1α in pulmonary cells, I found that in 
whole lung cells of the neonatal single-mutant mice, the single mutation of HIF-
3α -/- impaired the transcription of both HIF-1α and HIF-2α. Interestingly, the 
double-mutation even much further suppressed the expression of HIF-1α and 
HIF-2α genes in lung cells of the neonatal double-mutant mice (Figure 8).  
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Figure 8. The neonatal double-mutant mouse lung cells exhibited suppressed 
expressions of HIF-1α and HIF-2α. The utilizing qPCR performed the analysis of 
mRNA relative expressions for HIF-1α, HIF-2α. WT, wild-type, H3, hypoxia-
inducible factor 3α; H2, hypoxia-inducible factor 2α; ::, intercrossed with; -/-, 
knockout; kd/kd, knockdown; HIF-1α, hypoxia-inducible factor 1α; HIF-2α, 
hypoxia-inducible factor 2α; mRNA, messenger ribonucleic acid. ****p<0.0001, 
***p<0.001, **p<0.01, *p<0.05, ns: no significance. 
 
2.3.6. The neonatal double-mutant mouse lung cells exhibited the 
downregulation of HIF-target genes denoted by VE-cadherin, VCAM-1, 
Ang-2, Tie-2, and VEGF 
Next, the relative mRNA expression levels of HIF-target genes denoted by 
VE-cadherin, VCAM-1, angiopoietin 1 (Ang-1) and 2 (Ang-2), Tie-2, vascular 
endothelial growth factor (VEGF), and Flk-1 were analyzed. The analysis 
utilized the whole lung tissue from the neonatal WT, HIF-2α kd/kd, single-
mutant, and double-mutant mice at two to three days of age. In whole lung cells 
of the neonatal single-mutant mice, the single mutation of HIF-3α -/- reduced 
expression of VE-cadherin and VCAM-1. Furthermore, consistent with the 
impaired expression of VE-cadherin and VCAM-1 in lung tissues of the neonatal 
double-mutant mice, the whole lung cells from the neonatal double-mutant mice 
showed the downregulation of these adhesion molecules (Figure 9).   
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Figure 9. The neonatal double-mutant mouse lung cells showed the decreased 
expressions of adhesion molecules, VE-cadherin and VCAM-1. The utilizing 
qPCR performed the analysis of mRNA relative expressions for VE-cadherin and 
VCAM-1. WT, wild-type, H3, hypoxia-inducible factor 3α; H2, hypoxia-
inducible factor 2α; ::, intercrossed with; -/-, knockout; kd/kd, knockdown; 
VCAM-1, vascular cell adhesion molecule 1; VE-cadherin, vascular endothelial 
cadherin; mRNA, messenger ribonucleic acid. ****p<0.0001, ***p<0.001, 
**p<0.01, *p<0.05. 
 
In addition to the adhesion molecules, I found the impaired expression of other 
genes that related to the angiogenesis in whole lung cells of the neonatal single-
mutant and double mutant mice. The Ang-1, Ang-2, and Tie-2 expressions were 
reduced in the lung of the neonatal single-mutant mice and Ang-2 and Tie-2, 
respectively, even more, depressed in the lung of the neonatal double-mutant 
mice (Figure 10). The result also exhibited that, unexpectedly, Ang-1 was 
expressed excessively in the lung of the neonatal double-mutant mice.  
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Figure 10. The double-mutant mouse lung cells exhibited depressed expressions 
of angiogenic factors denoted by Ang-2 and Tie-2. The utilizing qPCR performed 
the analysis of mRNA relative expressions for Ang-2, Tie-2, VGEF, Ang-1, and 
Flk-1 that normalized to β-actin. Ang-1, angiopoietin 1; Ang-2, angiopoietin 2; 
VEGF, vascular endothelial growth factor; WT, wild-type, H3, hypoxia-inducible 
factor 3α; H2, hypoxia-inducible factor 2α; ::, intercrossed with; -/-, knockout; 
kd/kd, knockdown; mRNA, messenger ribonucleic acid. ****p<0.0001, 
***p<0.001, **p<0.01, *p<0.05, ns: no significance. 
 
2.3.7. The neonatal double-mutant mice showed the decreased endothelial 
cell numbers 
The previous study showed that the single-mutation of HIF-3α -/- impaired the 
proliferation and functions of pulmonary endothelial cells [41]. In the present 
study, I found that the double-mutation caused the abnormal appearance of blood 
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vessels in the lungs of the mice suggesting the involvement of endothelial cells in 
this phenomenon. Therefore, next, I examined the effect of the double-mutation 
on the endothelial cell numbers in the neonatal double-mutant mice lung. I 
performed the immunohistochemistry analysis of sections from the neonatal WT 
and double-mutant mice at two to three days of age (Figure 11) by CD31, a 
marker of endothelial cells. As expected, I found that consistent with the impaired 
lung vessel structure, the neonatal double-mutant mice showed the decreased 
pulmonary endothelial cell numbers. Particularly, the counting of the CD31 
positive cell number per field in 200x higher magnification showed that the 
neonatal WT mice had 156.3 ± 11.1 and the neonatal double-mutant mice had 
much lower, 44.3 ± 6.03 (n=3; p=0.000104) (Figure 12). 
 
Figure 11. Immunohistochemistry analysis performed to sections from the 
neonatal WT and double-mutant mice at two to three days of age by staining with 
the CD31 antibody. H3, hypoxia-inducible factor 3α; H2, hypoxia-inducible 
factor 2α; ::, intercrossed with; -/-, knockout; kd/kd, knockdown; WT, wild-type; 
µm, micrometer.  
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Figure 12. CD31-positive cells calculated from sections from the neonatal WT 
and double-mutant mice at two to three days of age. H3, hypoxia-inducible factor 
3α; H2, hypoxia-inducible factor 2α; ::, intercrossed with; -/-, knockout; kd/kd, 
knockdown; WT, wild-type; µm, micrometer. ***p<0.001. 
 
2.4. Discussion 
Resulting from the diverse expression pattern yielded in the lung development, 
HIF-1α and HIF-2α may act dissimilar, and specific, roles in epithelial and vascular 
morphogenesis. The outcomes from various studies evaluating HIF-1α and HIF-2α 
loss-of-function models bolster this likelihood [19]. On the other hand, the study of 
the role of HIF-3α in lung development remains very limited; nevertheless, there is a 
previous study exhibited that adult single-mutant mice with HIF-3α -/- have impaired 
lung remodeling [26]. Another study on the lung endothelial cells of single-mutant 
mice with HIF-3α -/- further reported that the defect of HIF-3α induced HIF-2α 
overexpression resulting in the overproduction of VE-cadherin; hence, impaired the 
lung endothelial cells functions [41]. Regarding this, up to now, there is no report 
about the complete role of both HIF-3α and HIF-2α in lung development. In the 
current study, I hypothesized that inhibition of the overexpression of HIF-2α in the 
single-mutant mice with HIF-3α -/- may help to rescue the impaired lung effects due 
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to the single-mutation of HIF-3α -/-. In order to examine my hypothesis, I performed 
the current study by utilizing the double-mutant mice possessing both HIF-3α -/- and 
HIF-2α kd/kd and analyzing whether the impaired lung conditions, which caused by 
the single-mutation of HIF-3α -/-, can be rescued. 
This kind of interference to the distinct HIF genes exhibits the particular and 
critical role of the individual HIF isoforms (Table 1). Of the existed literature, the 
genetic ablation of HIF-1α or HIF-1β/ARNT produces in the fetal death at about E10, 
with advanced cardiovascular malformations [45–49]. Vice versa, loss of HIF-2α 
caused fetal death in around 50% of embryos, with the surviving offspring denoting 
impaired lung development, decreased the production of surfactant, postnatal 
respiratory distress, and neonatal lethality [45, 50]. The results that span from early 
embryonic lethality to adulthood in these HIF-2α -/- mice depend on the genetic 
background of the mice strain [51–54]. Even though homozygous ablation of HIF-1α 
or HIF-2α proven to be lethal, the heterozygous condition for either HIF surprisingly 
exhibits normal development, and survival until the adulthood on the animals [45, 50]. 
The architecture and pulmonary function appear visibly normal under normoxic 
conditions. 
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HIF-modified type 
 
Mice phenotype 
HIF-1α -/- Fetal death with severe cardiovascular 
malformations [45–47, 49] 
 
HIF-1β -/- or ARNT -/- 
 
Fetal death with severe cardiovascular 
malformations, defect on angiogenesis of 
the yolk sac and branchial arches, stunted 
development, and embryo wasting [48, 55] 
 
HIF-2α -/- 
 
Fetal death in around 50% of embryos; the 
surviving offspring showed impaired lung 
development, decreased the production of 
surfactant, postnatal respiratory distress, 
and neonatal lethality [45, 50–54] 
 
HIF-2α +/- 
 
Normal development with the architecture 
and pulmonary function appear visibly 
normal under normoxic conditions and 
survival until adulthood [45, 50] 
 
HIF-2α kd/kd 
 
Grow well under normal conditions [43] 
 
HIF-3α -/- 
 
Alive at birth with impaired lung 
remodeling at the late embryonic stage 
showed by the walls of the secondary septa 
in subdivided alveoli, increase in defective 
space in the interalveolar septa, and 
hyperplasia of endothelial cells during the 
maturation of alveolar formation resulting 
in right ventricular enlargement in the adult 
stage [26] 
 
Table 1. The mice phenotype resulted from interference to the distinct HIF genes. 
ARNT, aryl hydrocarbon receptor nuclear translocator; HIF-1α, hypoxia-
inducible factor 1α; HIF-1β, hypoxia-inducible factor 1β; HIF-2α, hypoxia-
inducible factor 2α; HIF-3α, hypoxia-inducible factor 3α; -/-, knockout; +/-, 
knockout heterozygotes; kd/kd, knockdown. 
 
Of the little, I thought HIF-3α may play a substantive role as well during lung 
development. Nonetheless, its exact role in the pulmonary formation remains not well 
understood. A previous study showed the HIF-3α positive cells in the epithelium of 
the developing lung from the end of E18.5 and AT2 cells from the lungs of the adult 
mice of 8 weeks after birth [56]. Utilizing transgenic mice with an inducible HIF-3α 
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gene, the developing lung had no visible defects early during lung development; 
nonetheless, exhibited a late, post-pseudoglandular, branching morphogenesis defect 
accompanied by a decreased number of alveolar spaces and explicitly of AT1 and 
AT2 cells. It is suggested the non-apparent defects due to putative-related factors of 
HIF-3α, as of HIF-1α and HIF-2α, at the early stages of lung development. In 
addition, the role of HIF-3α in balancing the function of HIF regulated genes was 
found by the binding to the Sox2 promoter. HIF-3α expressions, and also HIF-1α and 
HIF-2α, is strictly regulated to make sure balance among the total number of proximal 
and distal cells [56].  
Of the first finding from my current study, I have elucidated the role of both 
HIF-3α and HIF-2α in lung development based on the result showed that no double-
mutant mice died immediately after birth. Most of the double-mutant mice were later 
died within one week postnatal because of respiratory failure. In relation to this, 
evaluation to the embryo development of the double-mutant mice at E12.5 showing 
that the double-mutant mice had not died embryonically, and vasculogenesis on yolk 
sac and hematopoiesis (fetal liver) were nothing different to other genotypes 
generated from the interbreeding clarified that the double-mutant mice have died later, 
but shown not immediately, after birth. This new finding is slightly opposed to the 
common knowledge that HIF deficiency is immediately postnatally lethal. Such 
double-mutant mice having inactivation of HIF-3α resulting in no outwardly apparent 
defects during embryo development followed with lethal later after birth, but not 
immediately, showed comparable results to the study findings generated from ectopic 
activation of HIF-3α [56]. The neonatal double-mutant mice possessing as well the 
reduced HIF-2α that still survived, and eventually died due to respiratory failure 
demonstrated also comparable findings to the study results generated either from 
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inactivation or ectopic activation of HIF-2α on a mixed genetic background of mice 
strain [51, 57], which the survived neonates dealt with respiratory distress and the 
deficiency of surfactant, and later afterward died. A lead to understanding the current 
study findings emerges from existing works derived from inactivation and ectopic 
expression studies [51, 57], which have shown that HIF-3α, as well HIF-2α, positively 
expressed in AT2 cells as the same place, suggesting that AT2 cells may demand 
distinct levels of HIF-3α and HIF-2α at different phases of the maturation of AT2 
cells. A further study needs to examine this hypothesis.   
Furthermore, my present study has also become the first report showing that 
the alveolar sacs of the mice with the double-mutation consisted of both HIF-3α -/- 
and HIF-2α kd/kd are impaired. This result has unexpectedly opposed the initial 
purpose of this study due to the double-mutation has not rescued the impaired lung 
because of the single-mutation. This current study result showed comparable findings 
that revealed incomplete alveolar sacs, together with some other complete alveolar 
sacs occasionally seen; similar appearance yet broadened the understanding to the 
previous study result observed in the P15 and adult of single-mutant mice having HIF-
3α -/- [26]. The explanation to the present findings, utilizing the double-mutant mice 
also having the reduced HIF-2α, may come from the defined role of HIF-2α as the key 
regulator in the formation of mature alveoli and AT2 cell differentiation [57] leading 
to the present result partly showed of alveolar maturation. The previous finding from 
Yamashita et al. utilizing the single-mutant mice with HIF-3α -/- [26] that exhibited 
incomplete alveolar spaces occasionally despite with the full presence of HIF-2α may 
show the importance of the defined HIF-3α presence in AT2 cells [56] to some extent 
in the alveolar maturation apart from the HIF-2α role. Further works are necessary to 
test this hypothesis.   
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Previous works had shown that HIF-1α and HIF-2α protein expressions in the 
embryonic lung of primates and sheep elevated in the third trimester; then, rapidly 
reduced at the time when delivery that leads to severe impacts on lung development: 
vascular and alveolar hypoplasia, bronchopulmonary dysplasia, and neonatal 
respiratory distress [27, 29]. In addition, the use of PHD inhibitors in vivo increasing 
HIF protein expressions rectify lung growth and function of premature baboon model 
[58, 59]; induction of HIF-1 protein in vitro in fetal lung buds is adequate to generate 
lung development including in non-hypoxic conditions [28]; and the antisense 
oligonucleotides declining HIF-1α lower lung branching morphogenesis and 
vascularization [35]. In my current study, utilizing mice without HIF-3α as in the 
single- and double-mutant mice resulting in the impaired expressions of both HIF-1α 
and HIF-2α in lung tissues based on immunological staining suggested the interaction 
among HIFs in lung development. There is the possibility that the expression of HIF-
3α was gradually reduced during development, which results in a reduced level of 
HIF-1α and HIF-2α. Further analysis of the expression of HIF-3α during development 
is necessary to clarify this issue. In the molecular level, I found the impairment of 
HIF-1α and HIF-2α in the neonatal double-mutant mice lung suggesting that the 
decreased of HIF-1α and HIF-2α expressions causing of lacking to overcome the 
happening of oxygen homeostasis disruption also deteriorated such lung alveolar 
structure. The neonatal double mutant mice lung showing also the impaired 
expression of HIF-target genes denoted by VE-cadherin and VCAM-1 are hence in 
parallel with the impaired expression of HIF-1α and HIF-2α. Such pathological 
features may provide further insight into the molecular mechanism of alveolar 
development especially for further investigation at the embryonic stage.  
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The effect of HIF-3α on HIF-2α expression has been reported previously. The 
increased HIF-3α expression resulted in a reduced level of HIF-2α, but not HIF-1α, in 
HIF-3α-transgenic mice [56]. In addition, the upregulation of HIF-2α was reported in 
the HIF-3α -/- lung endothelial cells [41]. Nevertheless, in my current study, I found 
the downregulation of both HIF-1α and HIF-2α in the single- and double-mutant mice. 
A previous study utilizing human umbilical venous endothelial cells showed that 
overexpression of IκBαm, an irreversible inhibitor of NF-κB, produces a very high 
inhibition to the upregulation of HIF-3α under hypoxia, but no changes under 
normoxia, and contributes to the mRNA and protein levels of HIF-1α and HIF-2α 
tend to decrease; hence, suggesting the regulation between HIFs by NF-κB [60]. On 
the other side, the combined siHIF-1α and siHIF-2α, but not each alone, produces a 
slight yet significant reduction of HIF-3α levels under hypoxia [60]. Therefore, I 
hypothesized the role of NF-κB in the downregulation of HIF-1α and HIF-2α in the 
single- and double-mutant mice.  
The current results on the gene expressions in the lung of the neonatal single-
mutant mice are acknowledged to be partly in line as well as in contrary to the results 
showed on the former study utilizing the adult single-mutant mice lung endothelial 
cells [41]. The contrary results in the current study are mostly correlated to the 
angiogenic gene regulations due to the depressed mRNA levels of HIF-1α, HIF-2α, 
VCAM-1, VE-cadherin, Ang-1, Ang-2, and Tie-2 in the lung of the neonatal single-
mutant mice. The mRNA levels of HIF-1α, HIF-2α, VCAM-1, VE-cadherin, Ang-2, 
and Tie-2 are even more depressed in the lung of the neonatal double-mutant mice. 
The contrast of the downregulation of both HIF-1α and HIF-2α on the current study 
findings with vice versa on the previous study by Kobayashi et al. despite with the 
same condition consisting of HIF-3α -/- suggests for the cell type-specific pattern of 
		
35			
HIF-3α function, as Augstein et al. had also proposed [60]. The understanding of 
those new findings may also apprehend in light of knowledge that HIF-2α has also 
presented in mesenchymal structures that provide the increase to the vascular 
endothelium, besides as well presented in the epithelium [28], and the 
angiopoietin/Tie-2 signaling pathways are vital for the maintenance of endothelial cell 
homeostasis [61–63], which can add to explain impaired alveolar sacs and lung 
alveolar structure conditions. Ang-1 that is interestingly highly expressed even though 
HIF-1α is expressed inversely in the lung of the neonatal double-mutant mice, which 
against the previous report concluding HIF-1α targets explicitly Ang-1 [64] may 
indicate other regulations involved.  
Hereof, it is understandable that studies of HIF-dependent responses on 
pulmonary vascular and airway epithelium are equally important. Kobayashi et al. 
reported that the pulmonary endothelial cells isolated from adult single-mutant mice 
exhibited impaired proliferation, migration ability, and angiogenic functions [41]. The 
present immunohistochemistry results from the lung tissues of the neonatal double-
mutant mice have further widened the comprehension showing the decreased of 
endothelial cell numbers. The phenomena of the decreased CD31 positive cell number 
of the neonatal double-mutant mice may implicate the suppression of the angiogenic 
factors. The immunohistochemistry data cannot clearly show the decreased VCAM-1 
and VE-cadherin expressions per one endothelial cell. Meanwhile, the depressed of 
mRNA expressions correlated with the angiogenic gene regulations occurred because 
already only slight endothelial cells persisted in the whole lung. Aside from the low 
pulmonary endothelial cell numbers, the impaired proliferative and angiogenic 
activities of these cells appeared to contribute on the structure impairment of lung 
alveolar of the neonatal double-mutant mice. Further experiments related to the 
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functions of pulmonary endothelial cells isolated from the double-mutant mice are 
required to reveal this hypothesis. 
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Chapter III. Conclusion and perspectives 
 
3.1. Conclusion 
In the present study, I demonstrated that the double-mutant mice having 
double-mutation, which resulted from interbreeding between male and female HIF-3α 
-/- and HIF-2α kd/+ mice showed no immediate death at birth. Of note, both HIF-3α 
and HIF-2α exhibited their roles in lung development of mice. The double mutant 
mice revealed the abnormal structure of lung alveolar and appearance of blood 
vessels.  
In addition, involving the impaired alveolar sacs of the double-mutant mice, I 
found the impaired expression of HIF-1α and HIF-2α in lung tissues of the neonatal 
double-mutant mice suggesting the lacking to overcome the oxygen homeostasis 
disruption, which deteriorated the lung alveolar structure. Lastly, there was the 
downregulation of angiogenic genes denoted by VCAM-1, VE-cadherin, Ang-2, and 
Tie-2 in lung cells isolated, and the decreased numbers of endothelial cells in lung 
tissues, from the neonatal double-mutant mice, which may be involved in the 
impaired vascularization leading subsequently to the abnormal appearance of blood 
vessels. 
 
3.2. Perspectives 
Although the common knowledge shows that HIF deficiency is immediately 
postnatally lethal, interestingly, my present study revealed even not all of the double-
mutant mice bringing the double-mutation condition died immediately after birth. 
Therefore, in perspective, the current study described quite appealing results and 
proposed insightful ideas of the role of both HIF-3α and HIF-2α in the survival and 
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lung development of mice. Nonetheless, there are still obstacles from the limited 
number of double-mutant mice that survive postnatally, which may hinder the 
acquisition of sufficient samples for the isolation and identification.  
Overall, the findings need to be further investigated to elucidate the impaired 
development occurred in the lung endothelial cells as well as alveolar epithelial cells, 
in particular for AT2 cells. The future plan for the current study finding will by then 
aim to know the functional role of double-mutation consisted of both HIF-3α -/- and 
HIF-2α kd/kd in lung endothelial cells and AT2 cells of the double-mutant mice. 
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